This result could easily be due to A3B upregulation occurring at variable times during the progression of individual breast tumours because the trend completely disappears in the analysis of subclonal APOBEC signature mutations where A3B has already been implicated strongly5, 6, 7, 8, 9, 10, 11, 12. Here, APOBEC3B is linked to breast neoplasm.